InChI=1S/C66H87N13O13/c1- 38(2) 32- 47- 59(85) 77- 52(36- 42- 20- 12- 7- 13- 21- 42) 66(92) 79- 31- 15- 23- 53(79) 64(90) 76- 49(34- 41- 18- 10- 6- 11- 19- 41) 61(87) 74- 48(33- 40- 16- 8- 5- 9- 17- 40) 60(86) 75- 51(37- 55(69) 82) 62(88) 70- 46(28- 29- 54(68) 81) 58(84) 73- 50(35- 43- 24- 26- 44(80) 27- 25- 43) 63(89) 78- 56(39(3) 4) 65(91) 71- 45(22- 14- 30- 67) 57(83) 72- 47/h5- 13,16- 21,24- 27,38- 39,45- 53,56,80H,14- 15,22- 23,28- 37,67H2,1- 4H3,(H2,68,81) (H2,69,82) (H,70,88) (H,71,91) (H,72,83) (H,73,84) (H,74,87) (H,75,86) (H,76,90) (H,77,85) (H,78,89) /t45- ,46- ,47- ,48+,49- ,50- ,51- ,52+,53- ,56- /m0/s1 |
GSXRBRIWJGAPDU-BBVRJQLQSA-N |
[H] [C@@] 1(Cc2ccc(O) cc2) NC(=O) [C@H] (CCC(N) =O) NC(=O) [C@H] (CC(N) =O) NC(=O) [C@@H] (Cc2ccccc2) NC(=O) [C@H] (Cc2ccccc2) NC(=O) [C@] 2([H] ) CCCN2C(=O) [C@@H] (Cc2ccccc2) NC(=O) [C@H] (CC(C) C) NC(=O) [C@H] (CCCN) NC(=O) [C@@H] (NC1=O) C(C) C |
|
Brevibacillus brevis
(NCBI:txid1393)
|
of strain
ATCC 8185
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
antibacterial agent
A substance (or active part thereof) that kills or slows the growth of bacteria.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via peptide antibiotic )
|
|
View more via ChEBI Ontology
cyclo(L- asparaginyl- L- glutaminyl- L- tyrosyl- L- valyl- L- ornithyl- L- leucyl- D- phenylalanyl- L- prolyl- L- phenylalanyl- D- phenylalanyl)
|
cyclo-(D-Phe-Pro-Phe-D-Phe-Asn-Gln-Tyr-Val-Orn-Leu)
|
ChEBI
|
cyclo-(D-PheProPhe-D-PheAsnGlnTyrValOrnLeu)
|
ChEBI
|
TrcA
|
ChEBI
|
505927
|
Reaxys Registry Number
|
Reaxys
|
8011-61-8
|
CAS Registry Number
|
KEGG COMPOUND
|
4320358
|
PubMed citation
|
Europe PMC
|
5900549
|
PubMed citation
|
Europe PMC
|
|